FDA orphan drug designation announced for childhood cancer vaccine

(Solving Kids' Cancer) The US Food and Drug Administration granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer.